Angela Öllinger

Incidence of hypertension in people with HIV who are treated with integrase inhibitors versus other antiretroviral regimens in the RESPOND cohort consortium

Dathan M. Byonanebye, Mark N. Polizzotto, Bastian Neesgaard et al. · HIV Medicine · 2022 · 65 citations · Full text

Public Health, Internal Medicine, Pharmacotherapy +17

Hereditary angioedema in Austria: prevalence and regional peculiarities

Clemens Schöffl, Michaela Wiednig, Lukas Koch et al. · JDDG Journal der Deutschen Dermatologischen Gesellschaft · 2019 · 36 citations · Full text

Medicine, Genetics, Internal Medicine +8

Uptake and Discontinuation of Integrase Inhibitors (INSTIs) in a Large Cohort Setting

Lauren Greenberg, Lene Ryom, Gilles Wandeler et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2020 · 34 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Real‐world outcomes using <scp>PD</scp>‐1 antibodies and <scp>BRAF</scp> + <scp>MEK</scp> inhibitors for adjuvant melanoma treatment from 39 skin cancer centers in Germany, Austria and Switzerland

Katharina Schumann, Cornelia Mauch, Kai‐Christian Klespe et al. · Journal of the European Academy of Dermatology and Venereology · 2022 · 29 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

A Single Quantifiable Viral Load Is Predictive of Virological Failure in Human Immunodeficiency Virus (HIV)-Infected Patients on Combination Antiretroviral Therapy: The Austrian HIV Cohort Study

Gisela Leierer, Katharina Grabmeier‐Pfistershammer, Andrea E. Steuer et al. · Open Forum Infectious Diseases · 2016 · 21 citations · Full text

Life Sciences, Infectious Diseases, Pharmacotherapy +10